Psychiatric news covered in this episode: FDA Grants Priority Review for MDMA Therapy, Benzodiazepine Withdrawal Perils, Lithium: Good for Bones?, Iloperidone Added to Anti-Psychotics with Mania Efficacy, Transdiagnostic Sleep and Circadian Treatment, A Door Closes for Clozapine-Resistant Schizophrenia, Therapy for Multi-Trauma PTSD.
Key strategies to empower you in reducing marijuana use among you. Join us as we delve into practical approaches to support teens in making healthier choices and navigating the stages of change.
You do not need to be an expert in borderline personality to help your patients. Dr. Mallo will introduce tactics that can be applied in different treatment settings.
Robert Meisner, MD, explores the latest developments in psychiatric treatment with ketamine and esketamine, including their differences and emerging insights for clinicians.
We no longer recommend medications as first-line treatment. Here are the current pharmacotherapy approaches for the treatment of insomnia. Here are the indications for the use of benzodiazepines, non-benzodiazepines, and sedating antidepressants, and we're going to understand the mechanism of action and how to use the newest medications, orexin antagonists.
What steps should clinicians take if psychopharmacologic treatments and school behavioral strategies are insufficient for managing a child with ADHD? We've all been there. ADHD, attention deficit hyperactivity disorder, of course, affects millions of children and adolescents worldwide and can significantly impact focus, impulses, and engagement with friends.
Parents and caregivers need to understand the different kinds of medications and therapies that are available to help manage ADHD. In this podcast, Mara and I will explore the various treatment options for ADHD in children and discuss how to navigate the process of selecting more effective treatments.
In today's episode, Dr. Brian Hurley provides expert insights into the current state of stimulant use disorder, its implications across different regions, and available treatment options.
Researchers found a connection between Alzheimer's disease and the use of contaminated growth hormone from human cadavers, highlighting the importance of understanding Alzheimer's pathology for better treatment development.